Tg Therapeutics (TGTX) Receivables - Net (2021 - 2025)
Historic Receivables - Net for Tg Therapeutics (TGTX) over the last 5 years, with Q3 2025 value amounting to $265.4 million.
- Tg Therapeutics' Receivables - Net rose 12931.9% to $265.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $265.4 million, marking a year-over-year increase of 12931.9%. This contributed to the annual value of $129.2 million for FY2024, which is 15284.29% up from last year.
- Latest data reveals that Tg Therapeutics reported Receivables - Net of $265.4 million as of Q3 2025, which was up 12931.9% from $231.5 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Receivables - Net ranged from a high of $265.4 million in Q3 2025 and a low of $88000.0 during Q2 2022
- In the last 5 years, Tg Therapeutics' Receivables - Net had a median value of $39.3 million in 2023 and averaged $70.7 million.
- Per our database at Business Quant, Tg Therapeutics' Receivables - Net crashed by 9054.78% in 2022 and then surged by 1976818.18% in 2023.
- Tg Therapeutics' Receivables - Net (Quarter) stood at $1.4 million in 2021, then plummeted by 93.66% to $88000.0 in 2022, then soared by 57960.23% to $51.1 million in 2023, then soared by 152.84% to $129.2 million in 2024, then soared by 105.43% to $265.4 million in 2025.
- Its Receivables - Net stands at $265.4 million for Q3 2025, versus $231.5 million for Q2 2025 and $190.1 million for Q1 2025.